Published in Arch Toxicol on January 01, 1974
Biomarkers of human exposure to pesticides. Environ Health Perspect (1997) 0.97
Pentachlorophenol and other chlorinated phenols are substrates for human hydroxysteroid sulfotransferase hSULT2A1. Chem Res Toxicol (2008) 0.92
Effects of pentachlorophenol and tetrachlorohydroquinone on mitogen-activated protein kinase pathways in Jurkat T cells. Environ Health Perspect (2002) 0.78
Chemoradiotherapy followed by surgery compared with surgery alone in squamous-cell cancer of the esophagus. N Engl J Med (1997) 4.94
Pharmacokinetics and metabolism of delta 1-tetrahydrocannabinol and other cannabinoids with emphasis on man. Pharmacol Rev (1986) 1.61
Functional aspects of developmental toxicity of polyhalogenated aromatic hydrocarbons in experimental animals and human infants. Eur J Pharmacol (1995) 1.54
Plasma delta-9 tetrahydrocannabinol concentrations and clinical effects after oral and intravenous administration and smoking. Clin Pharmacol Ther (1980) 1.43
The combination of gas chromatography and mass spectrometry in the identification of drugs and metabolites. Adv Pharmacol Chemother (1969) 1.29
Chlorinated phenols: occurrence, toxicity, metabolism, and environmental impact. Crit Rev Toxicol (1980) 1.26
Preoperative radiochemotherapy in rectal cancer: long-term results of a phase II trial. Int J Radiat Oncol Biol Phys (2000) 1.10
Impact of intravascular ultrasound guidance in stent deployment on 6-month restenosis rate: a multicenter, randomized study comparing two strategies--with and without intravascular ultrasound guidance. RESIST Study Group. REStenosis after Ivus guided STenting. J Am Coll Cardiol (1998) 1.09
Comparison of risk patterns in carcinoma and melanoma of the skin in men: a multi-centre case-case-control study. Br J Cancer (2006) 1.08
Swedish dioxin survey: evaluation of the H-4-II E bioassay for screening environmental samples for dioxin-like enzyme induction. Pharmacol Toxicol (1991) 1.07
Role of alcohol and tobacco in the aetiology of head and neck cancer: a case-control study in the Doubs region of France. Eur J Cancer B Oral Oncol (1995) 1.05
Report of the WHO working group on the assessment of health risks for human infants from exposure to PCDDs, PCDFs and PCBs. Chemosphere (1999) 1.05
Occurrence of and risk factors for electroencephalogram burst suppression during propofol-remifentanil anaesthesia. Br J Anaesth (2011) 0.99
Metabolic activation and mutagenicity of 4 vinylic monomers (vinyl chloride, styrene, acrylonitrile, butadiene). Toxicol Eur Res (1981) 0.98
Relative liver tumour promoting activity and toxicity of some polychlorinated dibenzo-p-dioxin- and dibenzofuran-congeners in female Sprague-Dawley rats. Pharmacol Toxicol (1991) 0.96
Induction, modification and inhibition of rat liver microsomal benzo(a)pyrene hydroxylase; correlation with the S-9-mediated mutagenicity of benzo(a)pyrene. Biochem Biophys Res Commun (1978) 0.95
Do plasma concentrations of delta 9-tetrahydrocannabinol reflect the degree of intoxication? J Clin Pharmacol (1982) 0.95
The mutagenicity of butadiene towards Salmonella typhimurium. Toxicol Lett (1980) 0.94
Toxicity of PCB 77 (3,3',4,4'-tetrachlorobiphenyl) and PCB 118 (2,3',4,4'5-pentachlorobiphenyl) in the rat following subchronic dietary exposure. Fundam Appl Toxicol (1995) 0.94
Clinical effects and plasma levels of delta 9-tetrahydrocannabinol (delta 9-THC) in heavy and light users of cannabis. Psychopharmacology (Berl) (1981) 0.93
Single-dose kinetics of deuterium-labelled cannabidiol in man after smoking and intravenous administration. Biomed Environ Mass Spectrom (1986) 0.92
Antibodies against Echinococcus multilocularis alkaline phosphatase as markers for the specific diagnosis and the serological monitoring of alveolar echinococcosis. Parasite Immunol (1997) 0.92
Subchronic toxicity of 3,3',4,4',5-pentachlorobiphenyl in the rat. I. Clinical, biochemical, hematological, and histopathological changes. Fundam Appl Toxicol (1994) 0.91
Response shift effects on measuring post-operative quality of life among breast cancer patients: a multicenter cohort study. Qual Life Res (2012) 0.91
Mutagenicity of butadiene and butadiene monoxide. Biochem Biophys Res Commun (1978) 0.91
Fate and metabolism of some hallucinogenic indolealkylamines. Adv Pharmacol (1968) 0.91
A variable monilethrix phenotype associated with a novel mutation, Glu402Lys, in the helix termination motif of the type II hair keratin hHb1. J Invest Dermatol (1998) 0.91
Pharmacokinetics of clomethiazole in healthy adults. Acta Pharmacol Toxicol (Copenh) (1978) 0.90
[Familial blepharophimosis (study of 3 genealogies)]. Mars Med (1967) 0.90
Interactions of delta 1-tetrahydrocannabinol with cannabinol and cannabidiol following oral administration in man. Assay of cannabinol and cannabidiol by mass fragmentography. Experientia (1981) 0.90
[IFCT-0302 trial: randomised study comparing two follow-up schedules in completely resected non-small cell lung cancer]. Rev Mal Respir (2007) 0.90
French version of FACT-G: validation and comparison with other cancer-specific instruments. Eur J Cancer (2004) 0.89
Plasma kinetics of methaqualone in man after single oral doses. Eur J Clin Pharmacol (1973) 0.89
[Multisite validation study of questionnaire assessing out-patient satisfaction with care questionnaire in ambulatory chemotherapy or radiotherapy treatment]. Bull Cancer (2006) 0.88
Toxicity of polyalkylcyanoacrylate nanoparticles I: Free nanoparticles. J Pharm Sci (1982) 0.88
[Cutaneous drug-reactions to nevirapine: study of risk factors in 101 HIV-infected patients]. Ann Dermatol Venereol (2005) 0.87
The diagnosis of mucopolysaccharidoses by electron microscopy of skin biopsies. J Cutan Pathol (1975) 0.87
Alkaloids in certain species of Virola and other South American plants of ethnopharmacologic interest. Acta Chem Scand (1969) 0.87
Consumption of fatty fish from the Baltic Sea and PCB in whole venous blood, plasma and cord blood from delivering women in the Aland/Turku archipelago. J Toxicol Environ Health A (1998) 0.86
Metabolism of 5-methoxy-N,-N dimethyltryptamine- 14 C in the rat. Biochem Pharmacol (1969) 0.86
Effect on tissue vitamin A levels in the rat following subchronic exposure to four individual PCB congeners (IUPAC 77, 118, 126, and 153). Chemosphere (1995) 0.86
Validation of the French version of the colorectal-specific quality-of-life questionnaires EORTC QLQ-CR38 and FACT-C. Qual Life Res (2008) 0.86
Single dose kinetics of deuterium labelled delta 1-tetrahydrocannabinol in heavy and light cannabis users. Biomed Mass Spectrom (1982) 0.86
Differences in treatment and survival rates of non-small-cell lung cancer in three regions of France. Br J Cancer (1995) 0.86
Long-term quality of life in patients with rectal cancer treated with preoperative (chemo)-radiotherapy within a randomized trial. Cancer Radiother (2010) 0.86
Cocaine in blood of coca chewers. J Ethnopharmacol (1979) 0.85
A prospective randomized trial of idarubicin vs daunorubicin in combination chemotherapy for acute myelogenous leukemia of the age group 55 to 75. Leukemia (1996) 0.85
Liver tumour promoting activity of 3,4,5,3',4'-pentachlorobiphenyl and its interaction with 2,3,7,8-tetrachlorodibenzo-p-dioxin. Eur J Pharmacol (1995) 0.85
[Missing data mechanisms of the questionnaire SF-36's items in the SU.VI.MAX study]. Rev Epidemiol Sante Publique (2003) 0.84
Predictive value of admission hyperglycaemia on mortality in patients with acute myocardial infarction. Diabet Med (2006) 0.82
Plasma levels of delta 9-tetrahydrocannabinol after intravenous, oral, and smoke administration. NIDA Res Monogr (1981) 0.82
Marked alterations in retinoid homeostasis of Sprague-Dawley rats induced by a single i.p. dose of 10 micrograms/kg of 2,3,7,8-tetrachlorodibenzo-p-dioxin. Toxicology (1989) 0.82
Influence of experimental factors on the mutagenicity of vinylic monomers. Arch Toxicol Suppl (1980) 0.82
Diagnostic value of serum precipitins to mould antigens in active hypersensitivity pneumonitis. Eur Respir J (2006) 0.82
Retinol (vitamin A) inhibits the mutagenicity of o-aminoazotoluene activated by liver microsomes from several species in the Ames test. Mutat Res (1987) 0.82
Induction, activation, and inhibition of hamster and rat liver microsomal arylamide and arylamine N-hydroxylase. Cancer Res (1980) 0.81
Relative tumour promoting activity of three polychlorinated biphenyls in rat liver. Eur J Pharmacol (1993) 0.81
Characterization of the guinea pig liver microsomal 2-fluorenylamine and N-2-fluorenylacetamide N-hydroxylase. Cancer Lett (1980) 0.81
Subcellular fractionation of isolated rat hepatocytes. A comparison with liver homogenate. Biochim Biophys Acta (1980) 0.81
Plasma concentrations and effects of methaqualone after single and multiple oral doses in man. Eur J Clin Pharmacol (1974) 0.81
Interaction of 3,4,5,3',4'-pentachlorobiphenyl and 2,4,5,2',4',5'-hexachlorobiphenyl in promotion of altered hepatic foci in rats. Pharmacol Toxicol (1995) 0.81
Graft failure after T cell depleted HLA identical allogeneic bone marrow transplantation: risk factors in leukemic patients. Leuk Lymphoma (1993) 0.81
Toxicity of 2,2',4,4',5,5'-hexachlorobiphenyl in rats: effects following 90-day oral exposure. J Appl Toxicol (1997) 0.81
Glycation induction and antiglycation activity of skin care ingredients on living human skin explants. Int J Cosmet Sci (2011) 0.80
Effect of 2,3,7,8-tetrachlorodibenzo-p-dioxin on the hepatic storage of retinol in rats with different dietary supplies of vitamin A (retinol). Arch Toxicol (1980) 0.80
Response to chemotherapy after relapse in patients with or without previous adjuvant chemotherapy for breast cancer. The French Epirubicin Study Group. Cancer Treat Rev (1993) 0.80
Troubleshooting the rabbit ferric chloride-induced arterial model of thrombosis to assess in vivo efficacy of antithrombotic drugs. J Pharmacol Toxicol Methods (2012) 0.80
Identification of in vitro metabolites of delta 1-tetrahydrocannabinol formed by human livers. Drug Metab Dispos (1982) 0.80
The lateralizing and localizing value of adversion in epileptic seizures. Neurology (1983) 0.80
Non-mutagenicity of 2-methyl-2,3-epoxybutane and factors influencing the mutagenicity of 2,3-epoxybutane. J Appl Toxicol (1982) 0.80
Promotion of altered hepatic foci development in rat liver, cytochrome P450 enzyme induction and inhibition of cell-cell communication by DDT and some structurally related organohalogen pesticides. Carcinogenesis (1990) 0.80
Analyses of volatile transformation products from additives in gamma-irradiated polyethylene packaging. Food Addit Contam (2001) 0.80
Electrical stimulation of the human brain in epilepsy. Epilepsia (1990) 0.79
Adaptation to work load in squash players: laboratory tests and on court recordings. J Sports Med Phys Fitness (1987) 0.79
Inhibition of metabolic cooperation in vitro and enhancement of enzyme altered foci incidence in rat liver by the pyrethroid insecticide fenvalerate. Arch Toxicol (1988) 0.79
Polychlorinated and polybrominated biphenyl congeners and retinoid levels in rat tissues: structure-activity relationships. Toxicol Appl Pharmacol (1992) 0.79
Subchronic toxicity of 2,2',3,3',4,4'-hexachlorobiphenyl in rats. J Toxicol Environ Health (1997) 0.79
Alkaloid content of Banisteriopsis rusbyana. Am J Pharm Sci Support Public Health (1969) 0.79
Effects of specific dopaminergic agonists and antagonists in the open-field test. Pharmacol Biochem Behav (1991) 0.79
Retinol (vitamin A) as an inhibitor of the mutagenicity of aflatoxin B. Toxicol Lett (1980) 0.79
[An improved quality of life self-questionnaires specific for head and neck tumors]. Rev Epidemiol Sante Publique (1996) 0.79
Clozapine: an atypical neuroleptic. Neurosci Biobehav Rev (1990) 0.79
Evaluation properties of the French version of the OUT-PATSAT35 satisfaction with care questionnaire according to classical and item response theory analyses. Qual Life Res (2014) 0.78
Pressor response of oral tyramine in healthy men given amiflamine and placebo. Clin Pharmacol Ther (1986) 0.78
Metabolism of tetrachlorophenols in the rat. Arch Toxicol (1978) 0.78
Comparison between the effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin and six other compounds on the vitamin A storage, the UDP-glucuronosyltransferase and the aryl hydrocarbon hydroxylase activity in the rat liver. Arch Toxicol (1984) 0.78
Mutagenicity of vinyl chloride in the Ames test: possible artifacts related to experimental conditions. Mutat Res (1980) 0.78
Metabolism of pentachlorophenol in vivo and in vitro. Arch Toxicol (1978) 0.78
Biological implications of the reaction possibilities of the proximate carcinogenic compound, N-hydroxy-2-fluorenylacetamide. Biomed Mass Spectrom (1976) 0.78
Interaction between quercetin, TPA and DDT in the V79 metabolic cooperation assay. Carcinogenesis (1987) 0.78
Anxiolytic potential of sulpiride, clozapine and derivatives in the open-field test. Pharmacol Biochem Behav (1990) 0.78
Vitamin A (retinol) status in the rat after a single oral dose of 2,3,7,8-tetrachlorodibenzo-p-dioxin. Arch Toxicol (1979) 0.78
Promotion of altered hepatic foci by 2,3',4,4',5-pentachlorobiphenyl in Sprague-Dawley female rats. Fundam Appl Toxicol (1997) 0.78
Quantitation of 1-tetrahydrocannabinol in plasma from cannabis smokers. J Pharm Pharmacol (1973) 0.78
Peyote alkaloids: identification in a prehistoric specimen of lophophora from coahuila, Mexico. Science (1978) 0.77
Effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) on the vitamin A status of Hartley guinea pigs, Sprague-Dawley rats, C57Bl/6 mice, DBA/2 mice, and Golden Syrian hamsters. J Nutr Sci Vitaminol (Tokyo) (1991) 0.77
Relationship between brain levels of 3-(3-hydroxyphenyl)-N-n-propylpiperidine HCl enantiomers and effects on locomotor activity in rats. J Pharmacol Exp Ther (1992) 0.77